The FDA has approved Journavx, a new non-opioid pain medication designed to reduce addiction and overdose risks.

The FDA approved Vertex Pharmaceuticals' Journavx, a new non-opioid pain pill for short-term pain. While safer than opioids, ...

U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated ...

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the U.S. Food and Drug Administration (FDA) has ...

(Reuters) -The U.S. Food and Drug Administration has approved Vertex Pharmaceuticals (NASDAQ: VRTX )' drug to treat acute ...

BusinessWire India Accra [Ghana] Mumbai Maharashtra [India] January 31 Senator Dr Rasha Kelej CEO of Merck Foundation and President of More Than a Mother Campaign has been recognized as One of the 100 ...

Vertex Pharmaceuticals Incorporated today announced that the U.S. Food and Drug Administration (FDA) has approved JOURNAVXtm (suzetrigine), an oral, non-opioid, highly selective NaV1.8 pain signal ...

BusinessWire India Accra [Ghana] Mumbai Maharashtra [India] January 31 Senator Dr Rasha Kelej CEO of Merck Foundation and President of More Than a Mother Campaign has been recognized as One of the 100 ...

Tanzania President, Namibia President Elect and Merck Foundation Chief Executive Officer (CEO) named amongst 100 Most ...

Diabetes is a number of diseases that involve problems with the hormone insulin. There is no cure for diabetes. The warning signs of diabetes can be so mild that you don't notice them. That's ...

In the wake of federal pressure over its prescription costs, Cigna Group is looking to lower the out-of-pocket drug expenses that its patients face by matching the amount to employer contributions and ...

KDIGO guideline is the first specifically addressing autosomal dominant polycystic kidney disease (ADPKD) and focuses on some unique aspects of management.